SEC Form 4 · accession 0001225208-16-025766
Edwards Lifesciences Corp · EW
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Barbara J McNeil
Director
Period of report
Feb 4, 2016
Accepted (ET)
Feb 8, 2016 · 12:38 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001099800
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Feb 4, 2016 | S | 4,000 | $83.29 | D | 46,454 | I | By Trust |
| Common StockF3 | holding | — | — | — | 54,672 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1These shares were previously reported as directly owned and are now being reported as indirectly owned. On December 11, 2015, the common stock of Edwards Lifesciences Corporation split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.
- F2The Barbara J. McNeil Trust U/A DTD 6/17/1998
- F3Excludes shares previously reported as directly owned which are now being reported as indirectly owned. On December 11, 2015, the common stock of Edwards Lifesciences Corporation split 2-for-1, resulting in the reporting person's ownership of additional shares of common stock and stock options. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person.